RESUMEN

BACKGROUND: Mutations in the LMNA gene, encoding human lamin A/C, have been associated with an increasing number of disorders often involving skeletal and cardiac muscle, but no clear genotype/phenotype correlation could be established to date. METHODS: We analyzed the LMNA gene in a large cohort of patients mainly affected by neuromuscular or cardiac disease and clustered mutated patients in two groups to unravel possible correlations. RESULTS: We identified 28 variants, 9 of which reported for the first time. The two groups of patients were characterized by clinical and genetic differences: 1) patients with childhood onset displayed skeletal muscle involvement with predominant scapuloperoneal and facial weakness associated with missense mutations; 2) patients with adult onset mainly showed cardiac disorders or myopathy with limb girdle distribution, often associated with frameshift mutations presumably leading to a truncated protein. CONCLUSIONS: Our findings, supported by meta-analysis of previous literature, suggest the presence of two different pathogenetic mechanisms: late onset phenotypes may arise through loss of function secondary to haploinsufficiency, while dominant negative or toxic gain of function mechanisms may explain the severity of early phenotypes. This model of patient stratification may help patient management and facilitate future studies aimed at deciphering lamin A/C pathogenesis.

Asunto(s)

Predisposición Genética a la Enfermedad/genética , Cardiopatías/genética , Laminas/genética , Mutación/genética , Enfermedades Neuromusculares/genética , Adulto , Edad de Inicio , Niño , Preescolar , Análisis por Conglomerados , Estudios de Cohortes , Análisis Mutacional de ADN , Progresión de la Enfermedad , Mutación del Sistema de Lectura/genética , Marcadores Genéticos/genética , Haplotipos/genética , Cardiopatías/metabolismo , Cardiopatías/fisiopatología , Humanos , Lamina Tipo A/genética , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Músculo Esquelético/fisiopatología , Mutación Missense/genética , Miocardio/metabolismo , Miocardio/patología , Enfermedades Neuromusculares/metabolismo , Enfermedades Neuromusculares/fisiopatología , Fenotipo

RESUMEN

An 8-year-old boy was referred for recent onset of easy fatigue. He showed hyperCKemia and mild scapular winging. Muscle biopsy on the quadriceps muscle demonstrated slight fibre size variability. Dystrophin was normally distributed, carnitine palmitoyl transferase and glycolytic enzymes had normal activities. In the following years the patient developed exercise intolerance and myoglobinuria. Immunohistochemistry showed marked reduction of alpha-sarcoglycan, confirmed by Western blotting. Molecular analysis revealed compound heterozygosity with Arg284Cys and Glu137Lys substitutions, corresponding to nucleotide changes C850 T and G409 A in the gene. At present the patient, 20 years old, shows mild proximal weakness with prominent involvement of the paraspinal muscles, dorsal kyphosis and lumbar hyperlordosis. Exercise intolerance and myoglobinuria, already described in Becker muscular dystrophy, should be also considered among the possible presentations of sarcoglycan deficiencies.

Asunto(s)

Proteínas del Citoesqueleto/deficiencia , Tolerancia al Ejercicio , Glicoproteínas de Membrana/deficiencia , Distrofias Musculares/complicaciones , Mioglobinuria/complicaciones , Biopsia , Proteínas del Citoesqueleto/genética , Proteínas del Citoesqueleto/metabolismo , Humanos , Glicoproteínas de Membrana/genética , Proteínas de la Membrana/metabolismo , Músculo Esquelético/patología , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Mioglobinuria/genética , Sarcoglicanos , Espectrofotometría , Utrofina

RESUMEN

Four members of a family were found to carry the A3243G mtDNA mutation. Clinical features varied from typical MELAS to myoclonic epilepsy to simple deafness without neurological signs. Several other members of the family had symptoms consistent with a mitochondrial disease. Muscle biopsy in 3 of the 4 patients showed the most prominent mitochondrial alterations with partial deficiency of cytochrome c oxidase in the case with the mildest phenotype. Mitochondrial DNA analysis detected a variable percentage of A3243G mutation, roughly correlating with the phenotype. The interesting feature of the family lies in the great intrafamilial variability of the severity of clinical expression, encompassing MELAS and MERRF features, associated with the A3243G mtDNA mutation. A search for the most common mtDNA mutations is recommended in all patients featuring incomplete MELAS or MERRF syndromes and in all familial cases presenting minimal clinical signs.

Asunto(s)

Análisis Mutacional de ADN , ADN Mitocondrial/genética , Síndrome MELAS/genética , Síndrome MERRF/genética , ARN de Transferencia de Leucina/genética , Adulto , Biopsia , Femenino , Tamización de Portadores Genéticos , Humanos , Síndrome MELAS/diagnóstico , Síndrome MELAS/patología , Síndrome MERRF/diagnóstico , Síndrome MERRF/patología , Masculino , Persona de Mediana Edad , Músculo Esquelético/patología , Linaje , Fenotipo

RESUMEN

The hallmark of the lesions in multiple sclerosis (MS) is inflammatory demyelination with sparing of axons. Recent neuropathological and neuroradiological investigations show that structural changes of the axons occur, both in plaques and in the normal appearing white matter. A better understanding of the axonal damage in MS is important, since this may be responsible for permanent disability. We have investigated the immunoreactivity for ubiquitin, a sensitive method to detect axonal dystrophy and accumulation of abnormal proteins in pathological conditions of the nervous system, in the brains of six cases of MS (age range 39-66 years). Tissue blocks were fixed in formalin and embedded in paraffin. A panel of antibodies was used: anti-ubiquitin, anti-neurofilament (SMI-31 + SMI-32), anti-amyloid precursor protein and anti-PGP9.5. We focused our attention on chronic plaques, recognized by the absence of Luxol Fast Blue B-positive inclusions in macrophages. SMI-31 + SMI-32 showed the presence of a variable amount of axons within the plaques; the axonal network within the plaques was looser than outside. No ubiquitin reactivity was present in chronic plaques. In the normally myelinated white matter surrounding the plaques, a dense granular ubiquitin immunoreactivity was found both near and far from the plaque edge. No similar staining was found in control brains. Ubiquitination is the first step of a non-lysosomal degradation pathway of proteins. The present findings suggest a derangement of this proteolytic pathway in the axons outside the plaques, possibly as a consequence of chronic absence of myelin in the axonal segment inside the plaque. The spectrum of axonal changes in MS appears to be wider than expected and involves the apparently normal white matter.

Asunto(s)

Esclerosis Múltiple/metabolismo , Esclerosis Múltiple/patología , Fibras Nerviosas Mielínicas/patología , Ubiquitina/metabolismo , Adulto , Anciano , Humanos , Inmunohistoquímica , Microscopía Electrónica , Persona de Mediana Edad , Fibras Nerviosas Mielínicas/química , Fibras Nerviosas Mielínicas/ultraestructura , Proteínas de Neurofilamentos/análisis

RESUMEN

The skeletal muscle ryanodine receptor gene (RYR1; OMIM 180901) on chromosome 19q13.1 encodes the skeletal muscle calcium release channel. To date, more than 25 missense mutations have been identified in RYR1 and are associated with central core disease (CCD; OMIM 117000) and/or the malignant hyperthermia susceptibility phenotype (MHS1; OMIM 145600). The majority of RYR1 mutations are clustered in the N-terminal hydrophilic domain of the protein. Only four mutations have been identified so far in the highly conserved C-terminal region encoding the luminal/transmembrane domain of the protein which forms the ion pore. Three of these mutations have been found to segregate with pure or mixed forms of CCD. We have screened the C-terminal domain of the RYR1 gene for mutations in 50 European patients, diagnosed clinically and/or histologically as having CCD. We have identified five missense mutations (four of them novel) in 13 index patients. The mutations cluster in exons 101 and 102 and replace amino acids which are conserved in all known vertebrate RYR genes. In order to study the functional effect of these mutations, we have immortalized B-lymphocytes from some of the patients and studied their [Ca(2+)](i) homeostasis. We show that lymphoblasts carrying the newly identified RYR1 mutations exhibit: (i) a release of calcium from intracellular stores in the absence of any pharmacological activators of RYR; (ii) significantly smaller thapsigargin-sensitive intracellular calcium stores, compared to lymphoblasts from control individuals; and (iii) a normal sensitivity of the calcium release to the RYR inhibitor dantrolene. Our data suggest the C-terminal domain of RYR1 as a hot spot for mutations leading to the CCD phenotype. If the functional alterations of mutated RYR channels observed in lymphoblastoid cells are also present in skeletal muscles this could explain the predominant symptom of CCD, i.e. chronic muscle weakness. Finally, the study of calcium homeostasis in lymphoblastoid cells naturally expressing RYR1 mutations offers a novel non-invasive approach to gain insights into the pathogenesis of MH and CCD.

Asunto(s)

Calcio/metabolismo , Membrana Celular/química , Músculo Esquelético/metabolismo , Mutación/genética , Miopatía del Núcleo Central/genética , Canal Liberador de Calcio Receptor de Rianodina/genética , Secuencia de Aminoácidos , Estudios de Cohortes , ADN/química , ADN/genética , Análisis Mutacional de ADN , Cartilla de ADN/química , Exones , Humanos , Datos de Secuencia Molecular , Miopatía del Núcleo Central/patología , Reacción en Cadena de la Polimerasa , Homología de Secuencia de Aminoácido

RESUMEN

We report a case of late onset of Becker's muscular dystrophy (BMD), diagnosed at the age of 60, which showed a very mild clinical course. Remarkably, the immunohistochemical pattern did not show significant alterations, while Western blotting disclosed low molecular weight dystrophin. DNA analysis showed a deletion of the exons 45-53 of the Xp21 gene, which is fairly typical of Becker's muscular dystrophy but not predictable of clinical course. The possibility of Xp21 muscular dystrophy must be considered in all myopathies of uncertain cause, also in elderly patients.

Asunto(s)

Deleción Cromosómica , Distrofina/genética , Distrofia Muscular de Duchenne/patología , Cromosoma X , Western Blotting , Mapeo Cromosómico , Exones/genética , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Músculo Esquelético/patología , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/genética , Examen Neurológico

Asunto(s)

Anomalías Múltiples/genética , Deleción Cromosómica , Cromosomas Humanos Par 22 , Anomalías Craneofaciales/genética , Atrofia Muscular/genética , Enfermedades Neuromusculares/genética , Anomalías Múltiples/diagnóstico , Adolescente , Biopsia , Anomalías Craneofaciales/diagnóstico , Creatina Quinasa/sangre , Glucógeno/metabolismo , Humanos , Masculino , Microscopía Electrónica , Músculo Esquelético/patología , Atrofia Muscular/diagnóstico , Enfermedades Neuromusculares/diagnóstico

Asunto(s)

Carcinoma de Células Renales/cirugía , Neoplasias Renales/cirugía , Síndromes Paraneoplásicos del Sistema Nervioso/fisiopatología , Síndromes Paraneoplásicos/fisiopatología , Adulto , Humanos , Masculino , Síndromes Paraneoplásicos/cirugía , Síndromes Paraneoplásicos del Sistema Nervioso/cirugía

Asunto(s)

Adenina , Antígenos CD/genética , Guanina , Cadenas alfa de Integrinas , Integrinas/genética , Polimorfismo Genético/genética , Marcadores Genéticos , Humanos , Enfermedades Musculares/genética , Mutación Missense/genética , Estudios Retrospectivos

RESUMEN

The authors describe a novel pathogenic G5540A transition in the mitochondrial transfer RNA (tRNA)Trp gene of a sporadic encephalomyopathy characterized by spinocerebellar ataxia. Clinical features also included neurosensorial deafness, peripheral neuropathy, and dementia. Biochemistry revealed a severe reduction of cytochrome c oxidase (COX) activity. Single-fiber PCR demonstrated higher levels of mutant genomes in COX-negative ragged red fibers than in normal fibers. These findings confirm that COX is more susceptible than other respiratory chain complexes to mutations in the mitochondrial tRNATrp gene.

Asunto(s)

Deficiencia de Citocromo-c Oxidasa , ADN Mitocondrial/genética , Encefalomiopatías Mitocondriales/diagnóstico , Encefalomiopatías Mitocondriales/genética , Mutación Puntual/genética , ARN de Transferencia de Triptófano/genética , Adulto , Biopsia , Análisis Mutacional de ADN , Demencia/etiología , Progresión de la Enfermedad , Resultado Fatal , Femenino , Pérdida Auditiva Sensorineural/etiología , Humanos , Mitocondrias Musculares/enzimología , Mitocondrias Musculares/patología , Encefalomiopatías Mitocondriales/complicaciones , Músculo Esquelético/enzimología , Músculo Esquelético/patología , Ataxias Espinocerebelosas/etiología

Asunto(s)

Cardiomiopatías/diagnóstico , Cardiomiopatías/genética , Salud de la Familia , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/genética , Cromosoma X , Anciano , Análisis Mutacional de ADN , Resultado Fatal , Femenino , Genotipo , Humanos , Masculino , Linaje , Fenotipo

RESUMEN

A 25-year-old woman with negative family history and delayed motor development presented hypotrophy of the right lower limb and calf hypertrophy since age 7 and she complained of muscle weakness since 23. Neurological examination showed a thin elongated face, high-arched palate, high-pitched voice, proximal wasting and weakness, impairment of distal muscles in the lower limbs. CK was 3, 034 U/l, EMG showed a myopathic pattern. Muscle biopsy displayed dystrophic features with diffuse dystrophin deficiency; immunoblotting demonstrated quantitative reduction of the protein and normal molecular weight. Lyonization study showed skewed X-inactivation with the maternal X active. Seven years' follow-up did not show progression of the disease.

Asunto(s)

Distrofina/deficiencia , Distrofina/genética , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Adulto , Biopsia , Progresión de la Enfermedad , Femenino , Regulación de la Expresión Génica , Tamización de Portadores Genéticos/métodos , Heterocigoto , Humanos , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Distrofias Musculares/patología , Factores Sexuales

RESUMEN

We report two carriers of Xp21 muscular dystrophy with unusual clinical manifestations and striking variability of dystrophin deficiency within the same muscle biopsy. The first patient was a 60-year-old nun with recent onset of cramps and proximal weakness, mimicking an acquired myopathy. Muscle biopsy disclosed slight alterations in one sample and severe dystrophic changes in another; dystrophin was absent in 7% fibers in the former specimen and in 60% in the second. X inactivation was skewed with 90% cells inactivating the same X chromosome. The second patient was a 17-year-old girl with hyperCKemia, learning disability and a family history of X-linked muscular dystrophy. Muscle biopsy displayed slight fiber size variability and some internal nuclei; dystrophin was absent only in one muscle fiber. A second sample with the same morphological features demonstrated dystrophin deficiency with mosaic distribution. The pattern of X inactivation was normal. These cases emphasize the variability of histopathological changes and dystrophin deficiency in Xp21 muscular dystrophy carriers and the risk of sampling errors in muscle biopsy.

Asunto(s)

Distrofias Musculares/patología , Adolescente , Femenino , Humanos , Persona de Mediana Edad , Músculos/patología , Distrofias Musculares/genética , Cromosoma X/genética

RESUMEN

We studied dystrophin with both immunohistochemistry and immunoblotting in 201 muscle biopsies stored in liquid nitrogen during the period 1985-92. The systematic use of dystrophin testing combined with DNA analysis and with 3-10 years follow-up of the patients yielded a significant modification of the diagnoses made previously and identified dystrophinopathies with unusual expression and course. Seventeen out of 152 (11.18%) diagnoses in males and 8 out of 49 (16.32%) in females were modified by dystrophin testing. Most diagnostic errors (9 out of 27 diagnoses) were in the group Becker muscular dystrophy-limb girdle muscular dystrophy, confirming the clinical overlap of the two diseases. Unusual expressions of dystrophinopathy included muscular dystrophy with early elbow contractures (two patients), recurrent myoglobinuria (one patient), dilating cardiomyopathy (two patients), myoglobinuria and associated dilating cardiomyopathy (one patient), very late-onset benign myopathy (two patients and one manifesting carrier) and congenital myopathy (one manifesting carrier). In the group 'idiopathic hyper-CKaemia', we did not find any dystrophinopathy in 34 males, whereas five out of nine females were found to be carriers. Immunohistochemical analysis of dystrophin using the monoclonal antibody against the C-terminus detected 99% of protein defects and was found to be the most cost-effective way of revealing dystrophinopathies. The combined use of immunohistochemical analysis with the antibody against the C-terminus and immunoblotting with the antibody against the core of the protein appears to be a highly reliable diagnostic approach (100% detection rate).

Asunto(s)

Distrofina/análisis , Músculos/patología , Distrofias Musculares/patología , Biopsia , Femenino , Humanos , Immunoblotting , Inmunohistoquímica , Masculino

RESUMEN

Recent data suggest that death of muscle cells during development and in selected pathological conditions occurs via apoptosis. We investigated the occurrence of apoptosis in normal and pathological human skeletal muscle, using in situ end-labeling (ISEL) to detect DNA fragmentation, and immunohistochemistry for the expression of tissue transglutaminase and interleukin-1beta-converting enzyme (ICE)-like proteases. In normal subjects, apoptotic myonuclei were occasionally observed as evidence of normal tissue turnover. Myonuclear apoptosis due to a deficit of trophic support from nerve cells also occurred in spinal muscular atrophies. No apoptosis of muscle cells was found in dystrophinopathies, myotonic dystrophy and inflammatory myopathies, suggesting that death of myofibers in those conditions is not due to activation of a gene-directed program of death. In dystrophinopathies and inflammatory myopathies, apoptosis was found in interstitial mononuclear cells, as a likely mechanism of clearance of the inflammatory infiltrates.

Asunto(s)

Apoptosis , Músculo Esquelético/patología , Enfermedades Musculares/patología , Adolescente , Adulto , Anciano , Caspasa 3 , Caspasas/análisis , Núcleo Celular/genética , Niño , Fragmentación del ADN , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Lactante , Persona de Mediana Edad , Desnervación Muscular , Músculo Esquelético/inervación , Músculo Esquelético/ultraestructura , Enfermedades Musculares/genética , Enfermedades Musculares/metabolismo , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Distrofias Musculares/patología , Miositis/genética , Miositis/metabolismo , Miositis/patología , Distrofia Miotónica/genética , Distrofia Miotónica/metabolismo , Distrofia Miotónica/patología , Transglutaminasas/análisis

RESUMEN

The authors studied skeletal muscle cell cultures from four control subjects, two patients with Duchenne muscular dystrophy, two Duchenne carriers and three patients with Becker muscular dystrophy with different phenotypes. Western blotting was performed on well-differentiated myotubes and compared with the results obtained in muscle tissue. In all cultures the band of dystrophin closely corresponded to the one observed in muscle tissue: both quantitative and qualitative defects were observed. This confirms the early expression of the Xp21 gene defect in uninnervated muscle cultures and supports the usefulness of muscle cultures both in diagnostic procedure and as a model to study the disease.

Asunto(s)

Distrofina/biosíntesis , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Cromosoma X , Adulto , Biopsia , Western Blotting , Células Cultivadas , Niño , Mapeo Cromosómico , Distrofina/análisis , Distrofina/genética , Humanos , Masculino , Músculo Esquelético/citología , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Distrofias Musculares/patología , Valores de Referencia

RESUMEN

The sister of a child affected by Duchenne muscular dystrophy (DMD) was referred for genetic counselling to assess the risk of her being a carrier. Her brother had died 15 years previously at the age of 8. There were no other affected males in the family. There were no methods for DNA investigation at the time of the child's death and the family had never been studied for linkage with polymorphic probes on the chromosomal region Xp21. The only tissue from which an assessment of the risk could be made by DNA linkage analysis was two of the child's deciduous teeth that the parents had kept. DNA was extracted using a protocol described for the recovery of ancient DNA from museum specimens and archaeological finds. Multiplex amplification did not reveal deletions in 19 exons spanning the hot-spot regions for deletions within the dystrophin gene in Xp21. Linkage analysis using three highly polymorphic microsatellites demonstrated that the sister had not received the X chromosome borne by her brother. These results show that DNA extracted from teeth is a reliable source for molecular diagnosis.

Asunto(s)

ADN/análisis , Heterocigoto , Distrofias Musculares/diagnóstico , Distrofias Musculares/genética , Diente Primario/química , Niño , ADN/genética , Exones , Femenino , Asesoramiento Genético , Ligamiento Genético , Humanos , Masculino , Linaje , Cromosoma X

RESUMEN

A 54-year-old farmer with a negative family history had had mild proximal weakness for the previous 4 years. Clinical examination showed marked scoliosis, barrel-shaped chest, diffuse hypotrophy, and mild proximal weakness. Creatine kinase was 938 U/l; electrocardiography and echocardiography were normal. EMG disclosed myopathic changes. Muscle biopsy showed slight, nonspecific alterations. Dystrophin was present and normally distributed with antibodies against the C-terminal and N-terminal, whereas it was not recognized by the antibody against the rod domain. Western blotting detected an abnormal molecular weight protein of 320 kd (normal, 427 kd). Southern blot analysis revealed a deletion from exon 21 to exon 44, corresponding to 26% of the coding region of dystrophin. Six years' follow-up did not disclose progression of the muscle disease.

Asunto(s)

Distrofina/genética , Eliminación de Gen , Distrofias Musculares/genética , Humanos , Masculino , Persona de Mediana Edad , Músculos/patología , Distrofias Musculares/patología , Distrofias Musculares/fisiopatología , Fenotipo

RESUMEN

The metachromatic dye-Ca++ATPase method, that in normal muscle distinguishes fiber types on the basis of their metachromatic or orthochromatic staining, was applied to 382 pathological muscle biopsies. Results were compared in serial sections with those obtained with the conventional ammonium sulphide method. In pathological muscle the metachromatic dye-Ca++ATPase method confirms the advantages already showed in normal muscle: fast and easy performance, neat fiber typing, simultaneous staining of nuclei. Moreover in pathological muscle the metachromatic dye-Ca++ATPase method showed some muscle changes which are missed by the conventional ammonium sulphide one, namely central nuclei, macrophagic invasion and some structural abnormalities. This allows immediate correlation between those alterations and fiber typing.

Asunto(s)

ATPasas Transportadoras de Calcio , Colorantes , Histocitoquímica/métodos , Músculos/enzimología , Músculos/patología , Biopsia , Humanos

RESUMEN

Central core disease (CCD) of muscle is an inherited myopathy which is closely associated with malignant hyperthermia (MH) in humans. CCD has recently been shown to be tightly linked to the ryanodine receptor gene (RYR1) and mutations in this gene are known to be present in MH. Mutation screening of RYR1 has led to the identification of two previously undescribed mutations in different CCD pedigrees. One of these mutations was also detected in an unrelated MH pedigree whose members are asymptomatic of CCD. The data suggest a model to explain how a single mutation may result in two apparently distinct clinical phenotypes.

Asunto(s)

Canales de Calcio/genética , Genes , Hipertermia Maligna/genética , Proteínas Musculares/genética , Mutación , Miopatías Nemalínicas/genética , Adolescente , Animales , Preescolar , Ligamiento Genético , Humanos , Mitocondrias/patología , Datos de Secuencia Molecular , Linaje , Fenotipo , Reacción en Cadena de la Polimerasa , Conejos , Canal Liberador de Calcio Receptor de Rianodina , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Especificidad de la Especie , Porcinos